101 related articles for article (PubMed ID: 21204851)
21. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
Guéry JC; Galbiati F; Smiroldo S; Adorini L
J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
[TBL] [Abstract][Full Text] [Related]
22. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
23. Immune response against protozoal and nematodal infection in mice with underlying Schistosoma mansoni infection.
Yoshida A; Maruyama H; Yabu Y; Amano T; Kobayakawa T; Ohta N
Parasitol Int; 1999 Mar; 48(1):73-9. PubMed ID: 11269328
[TBL] [Abstract][Full Text] [Related]
24. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.
Brunner C; Sindrilaru A; Girkontaite I; Fischer KD; Sunderkötter C; Wirth T
EMBO J; 2007 Jul; 26(13):3191-202. PubMed ID: 17568779
[TBL] [Abstract][Full Text] [Related]
25. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
26. Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice.
Thüring H; Stenger S; Gmehling D; Röllinghoff M; Bogdan C
Eur J Immunol; 1995 Dec; 25(12):3229-34. PubMed ID: 8566005
[TBL] [Abstract][Full Text] [Related]
27. Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes.
Soldera S; McSorley SJ; Glaichenhaus N
Eur J Immunol; 1997 Apr; 27(4):848-54. PubMed ID: 9130634
[TBL] [Abstract][Full Text] [Related]
28. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
Wakil AE; Wang ZE; Locksley RM
Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
[TBL] [Abstract][Full Text] [Related]
29. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
Li Y; Ishii K; Hisaeda H; Hamano S; Zhang M; Nakanishi K; Yoshimoto T; Hemmi H; Takeda K; Akira S; Iwakura Y; Himeno K
Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
[TBL] [Abstract][Full Text] [Related]
30. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
31. Co-infected C57BL/6 mice mount appropriately polarized and compartmentalized cytokine responses to Litomosoides sigmodontis and Leishmania major but disease progression is altered.
Lamb TJ; Graham AL; Le Goff L; Allen JE
Parasite Immunol; 2005 Sep; 27(9):317-24. PubMed ID: 16149989
[TBL] [Abstract][Full Text] [Related]
32. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
[TBL] [Abstract][Full Text] [Related]
33. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes.
Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
J Immunol; 1997 Feb; 158(3):1246-53. PubMed ID: 9013966
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.
Reiling L; Jacobs T; Kroemer M; Gaworski I; Graefe S; Clos J
Infect Immun; 2006 Nov; 74(11):6027-36. PubMed ID: 17057085
[TBL] [Abstract][Full Text] [Related]
35. Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response.
Nouir NB; Eschbach ML; Piédavent M; Osterloh A; Kingsley MT; Erttmann K; Brattig N; Liebau E; Fleischer B; Breloer M
Vaccine; 2012 Jan; 30(5):862-71. PubMed ID: 22172506
[TBL] [Abstract][Full Text] [Related]
36. Strongyloides infection in rodents: immune response and immune regulation.
Breloer M; Abraham D
Parasitology; 2017 Mar; 144(3):295-315. PubMed ID: 26905057
[TBL] [Abstract][Full Text] [Related]
37. Immune effector mechanism in parasitic infections.
Liew FY; Xu D; Chan WL
Immunol Lett; 1999 Jan; 65(1-2):101-4. PubMed ID: 10065634
[TBL] [Abstract][Full Text] [Related]
38. Counterregulation of Th2 immunity by interleukin 12 reduces host defenses against Strongyloides venezuelensis infection.
Machado ER; Carlos D; Lourenço EV; Sorgi CA; Silva EV; Ramos SG; Ueta MT; Aronoff DM; Faccioli LH
Microbes Infect; 2009 Apr; 11(5):571-8. PubMed ID: 19344783
[TBL] [Abstract][Full Text] [Related]
39. Reversal of polarized T helper 1 and T helper 2 cell populations in murine leishmaniasis.
Coffman RL; Correa-Oliviera R; Mocci S
Ciba Found Symp; 1995; 195():20-5; discussion 25-33. PubMed ID: 8724828
[TBL] [Abstract][Full Text] [Related]
40. Coinfection with Toxoplasma gondii inhibits antigen-specific Th2 immune responses, tissue inflammation, and parasitism in BALB/c mice infected with Leishmania major.
Santiago HC; Oliveira MA; Bambirra EA; Faria AM; Afonso LC; Vieira LQ; Gazzinelli RT
Infect Immun; 1999 Sep; 67(9):4939-44. PubMed ID: 10456955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
